Goldman Sachs Group Inc Poseida Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 607,358 shares of PSTX stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
607,358
Previous 501,860 21.02%
Holding current value
$1.65 Million
Previous $1.47 Million 18.57%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.7 - $4.04 $284,844 - $426,211
105,498 Added 21.02%
607,358 $1.74 Million
Q2 2024

Aug 13, 2024
BUY
$2.0 - $3.46 $102,686 - $177,646
51,343 Added 11.4%
501,860 $1.47 Million
Q1 2024

May 15, 2024
SELL
$2.76 - $4.13 $56,455 - $84,479
-20,455 Reduced 4.34%
450,517 $1.44 Million
Q4 2023

Feb 13, 2024
BUY
$1.83 - $3.51 $7,083 - $13,587
3,871 Added 0.83%
470,972 $1.58 Million
Q3 2023

May 14, 2024
SELL
$1.62 - $2.79 $6,271 - $10,800
-3,871 Reduced 0.82%
467,101 $1.11 Million
Q3 2023

Nov 14, 2023
BUY
$1.62 - $2.79 $352,364 - $606,850
217,509 Added 87.15%
467,101 $1.11 Million
Q2 2023

May 14, 2024
SELL
$1.66 - $3.4 $72,658 - $148,818
-43,770 Reduced 14.92%
249,592 $439,000
Q2 2023

Aug 14, 2023
SELL
$1.66 - $3.4 $72,658 - $148,818
-43,770 Reduced 14.92%
249,592 $439,000
Q1 2023

May 14, 2024
BUY
$3.08 - $8.73 $507,118 - $1.44 Million
164,649 Added 127.92%
293,362 $903,000
Q1 2023

May 11, 2023
BUY
$3.08 - $8.73 $507,118 - $1.44 Million
164,649 Added 127.92%
293,362 $903,000
Q4 2022

May 14, 2024
BUY
$3.33 - $6.38 $181,714 - $348,150
54,569 Added 73.6%
128,713 $682,000
Q4 2022

Feb 13, 2023
BUY
$3.33 - $6.38 $181,714 - $348,150
54,569 Added 73.6%
128,713 $682,000
Q3 2022

May 14, 2024
BUY
$2.43 - $4.51 $71,512 - $132,724
29,429 Added 65.81%
74,144 $262,000
Q3 2022

Nov 10, 2022
BUY
$2.43 - $4.51 $71,512 - $132,724
29,429 Added 65.81%
74,144 $0
Q2 2022

May 14, 2024
SELL
$1.87 - $5.0 $797,100 - $2.13 Million
-426,257 Reduced 90.51%
44,715 $116,000
Q2 2022

Aug 15, 2022
SELL
$1.87 - $5.0 $21,994 - $58,810
-11,762 Reduced 20.83%
44,715 $116,000
Q1 2022

May 16, 2022
SELL
$3.22 - $7.04 $69,085 - $151,043
-21,455 Reduced 27.53%
56,477 $253,000
Q4 2021

Feb 14, 2022
BUY
$6.23 - $7.6 $129,316 - $157,753
20,757 Added 36.3%
77,932 $531,000
Q3 2021

Nov 10, 2021
BUY
$7.09 - $10.71 $405,370 - $612,344
57,175 New
57,175 $416,000

Others Institutions Holding PSTX

# of Institutions
98
Shares Held
38.5M
Call Options Held
377K
Put Options Held
22.2K
View Full List

About Poseida Therapeutics, Inc.

PSTX Quotes by TradingView
  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $233M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email